{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:38:23Z","timestamp":1792715903785,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2019\/006013"],"award-info":[{"award-number":["CRG\/2019\/006013"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council of Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["HCP-041"],"award-info":[{"award-number":["HCP-041"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijbiomac.2023.124772","type":"journal-article","created":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T21:19:48Z","timestamp":1683753588000},"page":"124772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"P2","title":["Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro"],"prefix":"10.1016","volume":"242","author":[{"given":"Bhavita","family":"Kattula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharati","family":"Reddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Jangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lekhika","family":"Naik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bala Manikanta","family":"Adimoolam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh","family":"Vavilapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayanna","family":"Are","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadeshwar Reddy","family":"Thota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender Singh","family":"Jadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Arifuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Addlagatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.124772_bb0005","article-title":"Insight of smart biosensors for COVID-19: a review","author":"Tomichan","year":"2022","journal-title":"Luminescence"},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0010","first-page":"13","article-title":"Laboratory-based diagnostic tools for COVID-19: an overview of challenges and limitations","author":"Shukla","year":"2022","journal-title":"Curr. Appl. Sci."},{"issue":"7894","key":"10.1016\/j.ijbiomac.2023.124772_bb0015","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/d41586-022-00112-8","article-title":"Why scientists are racing to develop more COVID antivirals","volume":"601","author":"Kozlov","year":"2022","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.124772_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268909","article-title":"Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: a molecular docking analysis","volume":"17","author":"Khater","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0025","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43094-022-00423-7","article-title":"Review on development of potential inhibitors of SARS-CoV-2 main protease (M(Pro))","volume":"8","author":"Katre","year":"2022","journal-title":"Future J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.876212","article-title":"Inhibitors of SARS-CoV-2 PLpro","volume":"10","author":"Calleja","year":"2022","journal-title":"Front. Chem."},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.124772_bb0035","doi-asserted-by":"crossref","first-page":"6689","DOI":"10.1128\/JVI.02220-08","article-title":"Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling","volume":"83","author":"Frieman","year":"2009","journal-title":"J. Virol."},{"issue":"44","key":"10.1016\/j.ijbiomac.2023.124772_bb0040","doi-asserted-by":"crossref","first-page":"32208","DOI":"10.1074\/jbc.M704870200","article-title":"Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus","volume":"282","author":"Devaraj","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"50","key":"10.1016\/j.ijbiomac.2023.124772_bb0045","doi-asserted-by":"crossref","first-page":"34667","DOI":"10.1074\/jbc.M114.609644","article-title":"Crystal structure of the Middle East respiratory syndrome coronavirus (MERS-CoV) papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression","volume":"289","author":"Bailey-Elkin","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"7835","key":"10.1016\/j.ijbiomac.2023.124772_bb0050","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.106449","article-title":"SARS-CoV-2 proteases Mpro and PLpro: design of inhibitors with predicted high potency and low mammalian toxicity using artificial neural networks, ligand-protein docking, molecular dynamics simulations, and ADMET calculations","volume":"153","author":"Tumskiy","year":"2023","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0060","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3390\/ijms23010259","article-title":"A review of the current landscape of SARS-CoV-2 main protease inhibitors: have we hit the bullseye yet?","volume":"23","author":"Macip","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.822785","article-title":"Potential inhibitors targeting papain-like protease of SARS-CoV-2: two birds with one stone","volume":"10","author":"Jiang","year":"2022","journal-title":"Front. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.apsb.2020.08.014","article-title":"Crystal structure of SARS-CoV-2 papain-like protease","volume":"11","author":"Gao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0075","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.ijbiomac.2021.06.123","article-title":"A comprehensive survey upon diverse and prolific applications of chitosan-based catalytic systems in one-pot multi-component synthesis of heterocyclic rings","volume":"186","author":"Mousavi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105076","article-title":"Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: a review","volume":"114","author":"Mermer","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"22","key":"10.1016\/j.ijbiomac.2023.124772_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200440","article-title":"Recent drug development and medicinal chemistry approaches for the treatment of SARS-CoV-2 infection and COVID-19","volume":"17","author":"Ghosh","year":"2022","journal-title":"ChemMedChem"},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.124772_bb0090","doi-asserted-by":"crossref","first-page":"9376","DOI":"10.1021\/acs.jmedchem.2c00636","article-title":"Small-molecule thioesters as SARS-CoV-2 main protease inhibitors: enzyme inhibition, structure-activity relationships, antiviral activity, and X-ray structure determination","volume":"65","author":"Pillaiyar","year":"2022","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124772_bb0095","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1039\/D1MD00247C","article-title":"Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Bai","year":"2021","journal-title":"RSC Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106390","article-title":"Green and efficient one-pot three-component synthesis of novel drug-like furo[2,3-d]pyrimidines as potential active site inhibitors and putative allosteric hotspots modulators of both SARS-CoV-2 M(Pro) and PL(Pro)","volume":"135","author":"Mousavi","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0105","doi-asserted-by":"crossref","DOI":"10.2174\/1568026623666230126104156","article-title":"SAR based review on diverse heterocyclic compounds with various potential molecular targets in the fight against Covid-19: a medicinal chemist perspective","author":"Madan","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104639","article-title":"Quinolines, a perpetual, multipurpose scaffold in medicinal chemistry","volume":"109","author":"Yadav","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"29","key":"10.1016\/j.ijbiomac.2023.124772_bb0115","doi-asserted-by":"crossref","first-page":"18594","DOI":"10.1039\/D2RA02896D","article-title":"Recent advances in chemistry and therapeutic potential of functionalized quinoline motifs - a review","volume":"12","author":"Ajani","year":"2022","journal-title":"RSC Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124772_bb0120","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1021\/acsinfecdis.1c00083","article-title":"Quinoline and quinazoline derivatives inhibit viral RNA synthesis by SARS-CoV-2 RdRp","volume":"7","author":"Zhao","year":"2021","journal-title":"ACS Infect. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124772_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0030324","article-title":"Design of wide-spectrum inhibitors targeting coronavirus main proteases","volume":"3","author":"Yang","year":"2005","journal-title":"PLoS Biol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s42003-022-03090-9","article-title":"Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay","volume":"5","author":"Narayanan","year":"2022","journal-title":"Commun. Biol."},{"issue":"46","key":"10.1016\/j.ijbiomac.2023.124772_bb0135","doi-asserted-by":"crossref","first-page":"21035","DOI":"10.1021\/jacs.2c04626","article-title":"Dual inhibitors of main protease (M(Pro)) and cathepsin L as potent antivirals against SARS-CoV2","volume":"144","author":"Mondal","year":"2022","journal-title":"J. Am. Chem. Soc."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0140","first-page":"17","article-title":"High-throughput screening of SARS-CoV-2 main and papain-like protease inhibitors","volume":"14","author":"Zang","year":"2023","journal-title":"Protein Cell"},{"issue":"42","key":"10.1016\/j.ijbiomac.2023.124772_bb0145","doi-asserted-by":"crossref","first-page":"eabd4596","DOI":"10.1126\/sciadv.abd4596","article-title":"Activity profiling and crystal structures of inhibitor-bound SARS-CoV-2 papain-like protease: a framework for anti-COVID-19 drug design","volume":"6","author":"Rut","year":"2020","journal-title":"Sci. Adv."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124772_bb0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4155\/fmc-2021-0269","article-title":"Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening","volume":"14","author":"Zhang","year":"2022","journal-title":"Future Med. Chem."},{"issue":"6575","key":"10.1016\/j.ijbiomac.2023.124772_bb0155","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"issue":"7811","key":"10.1016\/j.ijbiomac.2023.124772_bb0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12033-021-00383-y","article-title":"Evaluating stability and activity of SARS-CoV-2 PLpro for high-throughput screening of inhibitors","volume":"64","author":"Arya","year":"2022","journal-title":"Mol. Biotechnol."},{"issue":"6489","key":"10.1016\/j.ijbiomac.2023.124772_bb0170","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124772_bb0175","first-page":"2535","article-title":"Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug","volume":"10","author":"Wang","year":"2020","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124772_bb0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1021\/acsptsci.2c00026","article-title":"Hit expansion of a noncovalent SARS-CoV-2 main protease inhibitor","volume":"5","author":"Glaser","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.124772_bb0185","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124772_bb0190","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124772_bb0195","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124772_bb0200","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124772_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105944","article-title":"Teicoplanin: an alternative drug for the treatment of COVID-19?","volume":"55","author":"Baron","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0210","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41467-021-21060-3","article-title":"Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors","volume":"12","author":"Osipiuk","year":"2021","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.124772_bb0215","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1021\/ja200820m","article-title":"Quantification of the electrophilic reactivities of aldehydes, imines, and enones","volume":"133","author":"Appel","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"61","key":"10.1016\/j.ijbiomac.2023.124772_bb0220","doi-asserted-by":"crossref","first-page":"8537","DOI":"10.1039\/D0CC03290E","article-title":"Imines as acceptors and donors in N-heterocyclic carbene (NHC) organocatalysis","volume":"56","author":"Das","year":"2020","journal-title":"Chem. Commun. (Camb.)"},{"key":"10.1016\/j.ijbiomac.2023.124772_bb0225","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3389\/fmicb.2020.01796","article-title":"Quinolines-based SARS-CoV-2 3CLpro and RdRp inhibitors and spike-RBD-ACE2 inhibitor for drug-repurposing against COVID-19: an in silico analysis","volume":"11","author":"Alexpandi","year":"2020","journal-title":"Front. Microbiol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.124772_bb0230","doi-asserted-by":"crossref","first-page":"05558","DOI":"10.1016\/j.heliyon.2020.e05558","article-title":"Structure-based drug designing of naphthalene based SARS-CoV PLpro inhibitors for the treatment of COVID-19","volume":"6","author":"Bhati","year":"2020","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124772_bb0235","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/acsinfecdis.0c00168","article-title":"Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease","volume":"6","author":"Freitas","year":"2020","journal-title":"ACS Infect. Dis."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.124772_bb0240","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1021\/acsmedchemlett.0c00521","article-title":"Identification of 14 known drugs as inhibitors of the main protease of SARS-CoV-2","volume":"11","author":"Ghahremanpour","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124772_bb0245","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.3390\/ijms22083957","article-title":"SARS-CoV-2 papain-like protease potential inhibitors\u2014in silico quantitative assessment","volume":"22","author":"Stasiulewicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.124772_bb0250","doi-asserted-by":"crossref","first-page":"8484","DOI":"10.1039\/C7RA11537G","article-title":"Recent advances in the chemistry of 2-chloroquinoline-3-carbaldehyde and related analogs","volume":"8","author":"Hamama","year":"2018","journal-title":"RSC Adv."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124772_bb0255","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13578-021-00564-x","article-title":"Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases","volume":"11","author":"Chen","year":"2021","journal-title":"Cell Biosci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0265","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1038\/s41467-021-23313-7","article-title":"Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives","volume":"12","author":"Amporndanai","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124772_bb0270","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1038\/s41598-021-83229-6","article-title":"Identification of ebselen and its analogues as potent covalent inhibitors of papain-like protease from SARS-CoV-2","volume":"11","author":"Weglarz-Tomczak","year":"2021","journal-title":"Sci. Rep."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023016665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023016665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:46:27Z","timestamp":1792712787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023016665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":54,"alternative-id":["S0141813023016665"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124772","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of 2-chloroquinoline based heterocyclic frameworks as dual inhibitors of SARS-CoV-2 MPro and PLPro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124772","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124772"}}